Kounis syndrome and ziprasidone.

Area of Science:

• Cardiology
• Allergy and Immunology
• Pharmacology

Background:

• Kounis syndrome (KS) links allergic reactions to acute coronary syndromes (ACS).
• KS presents in three distinct variants.
• Understanding drug-induced KS is crucial for clinical practice.

Observation:

• This report details a novel case of type 1 Kounis syndrome.
• The syndrome was secondary to the antipsychotic medication Ziprasidone.
• This represents a rare instance of drug-induced cardiac events.

Findings:

• Ziprasidone can precipitate a type 1 Kounis syndrome variant.
• The allergic response to Ziprasidone manifested as acute coronary syndrome.
• This case expands the known triggers for Kounis syndrome.

Implications:

• Clinicians should consider Kounis syndrome in patients with allergic reactions and cardiac symptoms.
• Awareness of Ziprasidone as a potential trigger is important for patient safety.
• Further research into drug-induced KS is warranted to improve diagnostic and treatment strategies.